New Delhi, June 22 (IANS) The postponement of the India‑Africa Forum Summit IV — originally scheduled for 28–31 May here — over “emerging public health situation” from Bundibugyo Ebola outbreaks underscored India’s emerging role as a rapid vaccine manufacturer for Africa, a new report has said.The postponement of the event spotlighted “India’s decisive role in fast-tracking the critical production of a vaccine via the Serum Institute of India (SII), positioning New Delhi as an indisp…
Latest Serum Institute of India News & Updates
New Delhi, June 21 (IANS) The postponement of the fourth India-Africa Forum Summit due to concerns over the ongoing Ebola outbreak in parts of Africa has highlighted India’s growing role in supporting the continent’s healthcare needs, particularly through vaccine development and manufacturing, according to a report.As per an analysis by IOL, the summit’s deferment has drawn attention to India’s swift efforts to support Africa’s response to the Bundibugyo Ebola virus outbreak reported in the Demo…
New Delhi, June 13 (IANS) India is set to play a key role in the global response to the ongoing Ebola outbreak in Central Africa, with the Serum Institute of India (SII) fast-tracking the development and production of a vaccine candidate targeting the Bundibugyo strain of the virus, according to a report.A report by Modern Diplomacy showed that the initiative is being undertaken in collaboration with the University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI), with su…
New Delhi, March 24 (IANS) A consortium led by Aditya Birla Group and the Times of India Group has acquired the defending Indian Premier League (IPL) champions Royal Challengers Bengaluru (RCB) for USD 1.78 billion (Rs 16,725 crore approx), a news report claimed on Tuesday.Bolt Ventures (Bolt) and Blackstone’s perpetual private equity strategy (BXPE, Blackstone) are the other members of the consortium that have jointly bought the Royal Challengers Bengaluru, one of the eight original franchises …
New Delhi, Jan 22 (IANS) Pharma tycoon Adar Poonawalla said he will make a ‘strong and competitive’ bid for securing the ownership of the reigning champions of the Indian Premier League (IPL), the Royal Challengers Bengaluru (RCB).”Over the next few months, we will be putting in a STRONG and COMPETITIVE bid for RCB, one of the best teams in the IPL,” Poonawalla, Chief Executive Officer of Pune-based vaccine-maker Serum Institute of India (SII) and Chairman of Poonawalla Fincorp, wrote in a p…